Recognition of Non-Operating Income and Expenses
The filing company (株式会社ディー・ウェスタン・セラピテクス研究所)
Bank deposits, borrowings from financial institutions, stock acquisition rights issued through a third-party allotment, foreign-currency-denominated assets
Interest received on bank deposits, interest paid on borrowings from financial institutions, the issuance of stock acquisition rights through a third-party allotment, and subsequent foreign exchange movements
For the three-month consolidated period of the third quarter: interest received of ¥1.848 million, interest paid of ¥4.620 million, share issuance costs of ¥2.372 million and foreign exchange losses of ¥3.324 million. For the nine-month consolidated cumulative period: interest received of ¥3.893 million, interest paid of ¥11.123 million, share issuance costs of ¥6.809 million and foreign exchange losses of ¥2.291 million. Recorded as non-operating income and non-operating expenses
The three-month consolidated period and nine-month consolidated cumulative period of the third quarter of the fiscal year ending December 2026
| Item | Details |
|---|---|
| Event name | Recognition of Non-Operating Income and Expenses |
| Date of occurrence | During the nine-month consolidated cumulative period from 1 January 2026 to 30 September 2026 (individual dates Not disclosed) |
| Subject Entity | The filing company (株式会社ディー・ウェスタン・セラピテクス研究所) |
| Target Locations / Products | Bank deposits, borrowings from financial institutions, stock acquisition rights issued through a third-party allotment, foreign-currency-denominated assets |
| Cause | Interest received on bank deposits, interest paid on borrowings from financial institutions, the issuance of stock acquisition rights through a third-party allotment, and subsequent foreign exchange movements |
| Amount of Impact on Business Performance | For the three-month consolidated period of the third quarter: interest received of ¥1.848 million, interest paid of ¥4.620 million, share issuance costs of ¥2.372 million and foreign exchange losses of ¥3.324 million. For the nine-month consolidated cumulative period: interest received of ¥3.893 million, interest paid of ¥11.123 million, share issuance costs of ¥6.809 million and foreign exchange losses of ¥2.291 million. Recorded as non-operating income and non-operating expenses |
| Accounting period in which recognized | The three-month consolidated period and nine-month consolidated cumulative period of the third quarter of the fiscal year ending December 2026 |
Items this document does not state (18)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.These comprise interest received on bank deposits, interest paid on borrowings from financial institutions, share issuance costs associated with the issuance of stock acquisition rights through a third-party allotment, and subsequent foreign exchange movements affecting foreign-currency-denominated assets.